首頁 > 市場調查報告書 > 製藥

基因治療學和RNAi

市場調查報告書

商品編碼

1863871

基因表現市場按產品類型、應用、技術、工作流程步驟、樣本類型、最終用戶和地區分類

Gene Expression Market, By Product Type, By Application, By Technology, By Workflow Stage, By Sample Type, By End User, By Geography

出版日期: 2025年10月22日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

基因表現市場預計到 2025 年價值 165.6 億美元，預計到 2032 年將達到 236.1 億美元，2025 年至 2032 年的複合年成長率為 5.2%。

報告範圍		報告詳情
基準年：	2024	2025年市場規模：	165.6億美元
性能數據：	2020年至2024年	預測期：	2025年至2032年
預測期（2025-2032年）複合年成長率：	5.20%	2032 年價值預測：	236.1億美元

基因表現是生物學中的一個基本過程，透過這個過程，DNA中編碼的遺傳訊息轉化為功能性蛋白質，驅動細胞活動並決定生物體的特徵。全球基因表現市場涵蓋了一系列技術、試劑、儀器和服務，旨在分析、量化和理解各種生物系統中的基因活性模式。這個快速發展的市場包括先進的分析平台，例如RNA定序、微陣列、定量PCR和次世代定序技術，使研究人員能夠解析複雜的基因調控機制。

該市場服務於多種應用領域，包括基礎研究、藥物發現與開發、個人化醫療、農業生物技術和臨床診斷。隨著基因組研究投入的不斷增加、遺傳疾病盛行率的上升以及精準醫療方法日益受到關注，基因表現市場已成為推動科學認知和治療性介入的關鍵力量。人工智慧 (AI) 和機器學習演算法與基因表現分析平台的融合，進一步革新了數據解讀能力，使研究人員能夠從海量基因組資料集中提取有意義的資訊，並加速生命科學領域的突破性發現。

市場動態

全球基因表現市場受多種關鍵因素驅動，這些因素正在從根本上改變分子生物學研究和臨床應用的模式。全球政府機構和私人組織對基因組研究經費的指數級成長是主要催化劑，使研究人員能夠投資先進的基因表現分析技術並擴展其研究能力。癌症、遺傳性疾病和複雜疾病的日益普遍，使得人們需要進行全面的基因表現分析，以了解疾病機制並開發標靶治療，這顯著推動了對先進分析平台的需求。

個人化醫療方法的日益普及，即根據個別基因譜客製化治療方案，顯著提高了臨床對精準基因表現分析的需求。此外，次世代定序、RNA定序和高通量篩檢平台等技術的進步，提高了分析精度並降低了營運成本，使基因表現分析更容易被科研機構和醫療機構所採用。然而，目前仍存在顯著的市場限制。先進的基因表現分析儀器需要大量的資金投入，這可能會限制其在新興市場小型研究機構和組織中的應用。此外，數據解讀的複雜性以及對專業生物資訊學知識的需求，也為缺乏足夠技術資源和熟練人員的機構帶來了障礙。

臨床應用的監管合規要求和漫長的核准流程可能會延緩市場滲透，並增加市場參與企業的研發成本。儘管面臨這些挑戰，基因表現分析在農業生物技術、環境監測和工業生物技術領域的日益廣泛的應用也帶來了巨大的機會。人工智慧 (AI) 和機器學習演算法的日益融合，為開發更先進的分析平台創造了機會，這些平台能夠處理複雜的基因組資料集，並為研究人員和臨床醫生提供可操作的見解。

本次調查的主要特點

本報告對全球基因表現市場進行了詳細分析，以 2024 年為基準年，給出了預測期（2025-2032 年）內的市場規模（十億美元）和復合年成長率（%）。
它還重點介紹了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
該研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
該報告根據以下參數對全球基因表現市場的主要參與者進行了分析：公司概況、產品系列、主要亮點、財務表現和策略。
本報告的研究結果將使負責人和企業經營團隊能夠就即將推出的產品、類型升級、市場擴張和行銷策略做出明智的決策。
本報告的目標受眾是全球基因表現市場的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過各種用於分析全球基因表現市場的策略矩陣輕鬆做出決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 16.56 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	5.20%	2032 Value Projection:	USD 23.61 Bn

Gene expression represents a fundamental biological process through which genetic information encoded in DNA is converted into functional proteins that drive cellular activities and determine organism characteristics. The global gene expression market encompasses a comprehensive range of technologies, reagents, instruments, and services designed to analyze, quantify, and understand gene activity patterns across various biological systems. This rapidly evolving market includes sophisticated analytical platforms such as RNA sequencing, microarrays, quantitative PCR, and next-generation sequencing technologies that enable researchers to decode complex gene regulatory mechanisms.

The market serves diverse applications spanning basic research, drug discovery and development, personalized medicine, agricultural biotechnology, and clinical diagnostics. With increasing investments in genomics research, rising prevalence of genetic disorders, and growing emphasis on precision medicine approaches, the gene expression market has become pivotal in advancing scientific understanding and therapeutic interventions. The integration of artificial intelligence and machine learning algorithms with gene expression analysis platforms is further revolutionizing data interpretation capabilities, enabling researchers to extract meaningful insights from vast genomic datasets and accelerate breakthrough discoveries in life sciences.

Market Dynamics

The global gene expression market is propelled by several key drivers that are fundamentally reshaping the landscape of molecular biology research and clinical applications. The exponential growth in genomics research funding from government agencies and private organizations worldwide serves as a primary catalyst, enabling researchers to invest in advanced gene expression analysis technologies and expand their investigative capabilities. The increasing prevalence of cancer, genetic disorders, and complex diseases necessitates comprehensive gene expression profiling to understand disease mechanisms and develop targeted therapeutic interventions, driving substantial demand for sophisticated analytical platforms.

The rising adoption of personalized medicine approaches, where treatment strategies are tailored based on individual genetic profiles, significantly amplifies the need for accurate gene expression analysis in clinical settings. Additionally, technological advancements in next-generation sequencing, RNA-seq methodologies, and high-throughput screening platforms are enhancing analytical precision and reducing operational costs, making gene expression analysis more accessible to research institutions and healthcare facilities. However, the market faces notable restraints including the high capital investment requirements for advanced gene expression analysis equipment, which can limit adoption among smaller research organizations and emerging market institutions. The complexity of data interpretation and the need for specialized bioinformatics expertise create barriers for organizations lacking adequate technical resources and skilled personnel.

Regulatory compliance requirements and lengthy approval processes for clinical applications can delay market penetration and increase development costs for market participants. Despite these challenges, significant opportunities emerge from the expanding applications of gene expression analysis in agricultural biotechnology, environmental monitoring, and industrial biotechnology sectors. The growing integration of artificial intelligence and machine learning algorithms presents opportunities to develop more sophisticated analytical platforms capable of processing complex genomic datasets and providing actionable insights for researchers and clinicians.

Key Features of the Study

This report provides in-depth analysis of the global gene expression market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global gene expression market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Thermo Fisher Scientific Inc, Agilent Technologies Inc, Illumina Inc, QIAGEN N.V, Bio-Rad Laboratories Inc, Roche Diagnostics, PerkinElmer Inc, Takara Bio Inc, Promega Corporation, GE Healthcare, Pacific Biosciences of California Inc, Oxford Nanopore Technologies, Fluidigm Corporation, Lonza Group Ltd, and Eurofins Genomics
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global gene expression market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global gene expression market

Market Segmentation

Product Type Insights (Revenue, USD Bn, 2020 - 2032)
- Instruments (PCR Systems, Next-Generation Sequencing Systems, Microarray Scanners, etc.)
- Consumables and Reagents (Kits, Assays and Probes, DNA Chips etc.)
- Software and Services
Application Insights (Revenue, USD Bn, 2020 - 2032)
- Drug Discovery and Development
- Clinical Diagnostics
- Research and Development
Technology Insights (Revenue, USD Bn, 2020 - 2032)
- DNA Microarray
- PCR-Based (qPCR, RT-PCR)
- RNA Sequencing (RNA-Seq)
- Northern Blotting
- Next-Generation Sequencing (NGS)
- Serial Analysis of Gene Expression (SAGE)
Workflow Stage Insights (Revenue, USD Bn, 2020 - 2032)
- Sample Collection and Preparation
- RNA Isolation and Purification
- cDNA Synthesis and Amplification
- Detection and Quantification
- Data Analysis and Interpretation
Sample Type Insights (Revenue, USD Bn, 2020 - 2032)
- Human Samples
- Animal Samples
- Microbial Samples
End User Insights (Revenue, USD Bn, 2020 - 2032)
- Academic and Research Institutes
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROs)
- Hospitals and Clinical Laboratories
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Thermo Fisher Scientific Inc
- Agilent Technologies Inc
- Illumina Inc
- QIAGEN N.V
- Bio-Rad Laboratories Inc
- Roche Diagnostics
- PerkinElmer Inc
- Takara Bio Inc
- Promega Corporation
- GE Healthcare
- Pacific Biosciences of California Inc
- Oxford Nanopore Technologies
- Fluidigm Corporation
- Lonza Group Ltd
- Eurofins Genomics

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Gene Expression Market, By Product Type
- Global Gene Expression Market, By Application
- Global Gene Expression Market, By Technology
- Global Gene Expression Market, By Workflow Stage
- Global Gene Expression Market, By Sample Type
- Global Gene Expression Market, By End User
- Global Gene Expression Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Gene Expression Market, By Product Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Instruments (PCR Systems, Next-Generation Sequencing Systems, Microarray Scanners, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Consumables and Reagents (Kits, Assays and Probes, DNA Chips, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Software and Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Gene Expression Market, By Application, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Drug Discovery and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Clinical Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Research and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Gene Expression Market, By Technology, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
DNA Microarray
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
PCR-Based (qPCR, RT-PCR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
RNA Sequencing (RNA-Seq)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Northern Blotting
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Next-Generation Sequencing (NGS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Serial Analysis of Gene Expression (SAGE)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Gene Expression Market, By Workflow Stage, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Sample Collection and Preparation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
RNA Isolation and Purification
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
cDNA Synthesis and Amplification
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Detection and Quantification
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Data Analysis and Interpretation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Gene Expression Market, By Sample Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Human Samples
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Animal Samples
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Microbial Samples
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Gene Expression Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Hospitals and Clinical Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Gene Expression Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Workflow Stage, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Workflow Stage, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Workflow Stage, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Workflow Stage, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Workflow Stage, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Workflow Stage, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

11. Competitive landscape

Thermo Fisher Scientific Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Agilent Technologies Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Illumina Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
QIAGEN N.V
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bio-Rad Laboratories Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Roche Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
PerkinElmer Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Takara Bio Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Promega Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GE Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pacific Biosciences of California Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Oxford Nanopore Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Fluidigm Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Lonza Group Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Eurofins Genomics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies